Platelet transfusion requirements during autologous peripheral blood progenitor cell transplantation correlate with the pretransplant platelet count

Bone Marrow Transplantation

Volumn 20, Issue 6, 1997, Pages 459-463

  Bolwell, B J ^a   Goormastic, M ^a   Andresen, S ^a   Overmoyer, B ^a   Pohlman, B ^a   Kalaycio, M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Autologous marrow transplantation; Platelet transfusions; Stem cells

Indexed keywords

BUSULFAN; CARBOPLATIN; CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOKINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA;

ACUTE LEUKEMIA; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOTRANSPLANTATION; BREAST CANCER; CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MYELOMA; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STEM CELL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

EID: 0030805970     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700920     Document Type: Article

References (22)

1. Appelbaum FR. Marrow transplantation for hematologic malignancies: a brief review of current status and future prospects. Semin Hematol 1988; 25 (Suppl. 3): 16-22.
2. Bolwell BJ. Autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma. Semin Hematol 1994; 21 (Suppl. 7): 86-95.
3. Bolwell BJ, Goormastic M, Yanssens T et al. Comparison of G-CSF with GM-CSF for mobilizing peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant. Bone Marrow Transplant 1994; 14: 913-918.
4. Chao NJ, Schriber JR, Grimes K et al. Granulocyte colony-stimulation factor 'mobilized' peripheral bood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 1993; 81: 2031-2035.
5. Peters WP, Rosner G, Ross M et al. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 1993; 81: 1709-1719.
6. Demirer T, Buckner CD, Appelbaum FR et al. Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia. Bone Marrow Transplant 1995; 15: 915-922.
7. Haynes A, Hunter A, McQuaker G et al. Engraftment characteristics of peripheral blood stem cells mobilized with cyclophosphamide and the delayed addition of G-CSF. Bone Marrow Transplant 1995; 16: 359-363.
8. Faucher C, le Corroller AG, Blaise D et al. Comparison of G-CSF-primed peripheral blood progenitor cells and bone marrow auto transplantation: clinical assessment and cost-effectiveness. Bone Marrow Transplant 1994; 14: 895-901.
9. Bolwell BJ, Fishleder A, Andresen SW et al. G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: parameters affecting bone marrow engraftment. Bone Marrow Transplant 1993; 12: 609-614.
10. Siena S, Bregni M, Brando B et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 400-409.
11. Passos-Coelho JL, Hayden GB, Davis JM et al. Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization. J Clin Oncol 1995; 13: 705-714.
12. Haas R, Wit B, Mohle H et al. Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support. Blood 1995; 85: 3754-3761.
13. Brandt SJ, Peters WP, Atwater SK et al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. New Engl J Med 1988; 318: 869-876.
14. Gorin NC, Coiffier B, Hayat M et al. Recombinant human granulocyte-macrophage colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin's Lymphoma: a double-blind placebo-controlled trial. Blood 1992; 80: 1149-1157.
15. Link H, Boogaerts MA, Carella AM et al. A controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor after total body irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for acute lymphoblastic leukemia or malignant lymphoma. Blood 1992; 80: 2188-2195.
16. Nemunaitis J, Rabinowe SN, Singer JW et al. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. New Engl J Med 1991; 324: 1773-1778.
17. Huan SD, Hester J, Spitzer G et al. Influence of mobilized peripheral blood cells on the hematopoietic recovery by autologous marrow and recombinant human granulocyte-macrophage colony-stimulating factor after high-dose cyclophosphamide, etoposide, and cisplatin. Blood 1992; 79: 3388-3393.
18. Brice P, Divine M, Marolleau JP et al. Comparison of auto-grafting using mobilized peripheral blood stem cells with and without granulocyte colony-stimulating factor in malignant lymphomas. Bone Marrow Transplant 1994; 14: 51-55.
19. Pettengell R, Morgenstern GR, Woll PJ et al. Peripheral blood progenitor cell transplantation in lymphoma leukemia using a single apheresis. Blood 1993; 82: 3770-3777.
20. Kaushansky K. Thombopoietin: the primary regulator of platelet production. Blood 1995; 86: 419-431.
21. Farese AM, Hunt P, Boone T, MacVittie TJ. Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates. Blood 1995; 86: 54-59.
22. Banu, N, Wang J, Deng B et al. Modulation of megakaryocytopoiesis by thrombopoietin: the c-Mpl Ligand. Blood 1995; 86: 1331-1338.